Discovery of a Selective PROTAC Degrading Untamable BCR::ABL1 Compound Mutants in Chronic Myelogenous Leukemia (CML)and Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)

被引：0
|
作者：
Rouhimoghadam, Milad [1 ]
Tang, Hua [2 ]
Bates, Briana [1 ]
Liao, Junzhuo [2 ]
Uribe-Cano, Daniela
Tang, Weiping [1 ,2 ]
Deininger, Michael [1 ]
机构：
[1] Versiti Blood Res Inst, Milwaukee, WI USA
[2] Univ Wisconsin Madison, Madison, WI USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CML; BCR::ABL1; PROTAC; degrader; TKI;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-305
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [31] CLINICAL IMPACT OF ABL1 KINASE AND IKZF1 MUTATIONS IN ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): MOLECULAR ANALYSIS OF CALGB 10001 AND 9665 (ALLIANCE)
    DeBoer, R.
    Mulkey, F.
    Koval, G.
    Wetzler, M.
    Marcucci, G.
    Stone, R. M.
    Larson, R. A.
    Geyer, S.
    Mullighan, C.
    Stock, W.
    HAEMATOLOGICA, 2014, 99 : 258 - 258
  • [32] Ponatinib-Resistance in a Human Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the T315M Mutation of the BCR/ABL1 Gene
    Nguyen, Thao
    Harama, Daisuke
    Tamai, Minori
    Kagami, Keiko
    Kasai, Shin
    Watanabe, Atsushi
    Akahane, Koshi
    Goi, Kumiko
    Inukai, Takeshi
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [33] Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Jabbour, Elias
    Koller, Paul B.
    Oehler, Vivian G.
    Jamy, Omer H.
    Mukherjee, Sudipto
    Hunter, Anthony M.
    Baer, Maria R.
    Beck, Joseph T.
    Chen, Zi
    Guo, Huanshan
    Fu, Lei
    Men, Lichuang
    Wang, Hengbang
    Yang, Dajun
    Zhai, Yifan
    Kantarjian, Hagop
    Jiang, Lixin
    Wang, Cunlin
    BLOOD, 2022, 140
  • [34] The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
    Thomas, Xavier
    Heiblig, Mael
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1061 - 1070
  • [35] Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148
    Dan, S
    Naito, M
    Tsuruo, T
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (08): : 710 - 715
  • [36] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    L Pajor
    JA Vass
    L Kereskai
    P Kajtár
    Á Szomor
    M Egyed
    J Iványi
    P Jáksó
    Leukemia, 2000, 14 : 1122 - 1126
  • [37] The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement
    Pajor, L
    Vass, JA
    Kereskai, L
    Kajtár, P
    Szomor, A
    Egyed, M
    Iványi, J
    Jáksó, P
    LEUKEMIA, 2000, 14 (06) : 1122 - 1126
  • [38] A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    Seymour, J. F.
    Kim, D. W.
    Rubin, E.
    Haregewoin, A.
    Clark, J.
    Watson, P.
    Hughes, T.
    Dufva, I.
    Jimenez, J. L.
    Mahon, F-X
    Rousselot, P.
    Cortes, J.
    Martinelli, G.
    Papayannidis, Cristina
    Nagler, A.
    Giles, F. J.
    BLOOD CANCER JOURNAL, 2014, 4 : e238 - e238
  • [39] A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    J F Seymour
    D W Kim
    E Rubin
    A Haregewoin
    J Clark
    P Watson
    T Hughes
    I Dufva
    J L Jimenez
    F-X Mahon
    P Rousselot
    J Cortes
    G Martinelli
    C Papayannidis
    A Nagler
    F J Giles
    Blood Cancer Journal, 2014, 4 : e238 - e238
  • [40] Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL): Data from a Nationwide Belgian Registry
    Devos, Timothy
    Havelange, Violaine
    Theunissen, Koen
    Meers, Stef
    Benghiat, Fleur Samantha
    Gadisseur, Alain
    Vanstraelen, Gaetan
    Andre, Marc
    Bailly, Benjamin
    Granacher, Nikki
    Lewalle, Philippe
    De Becker, Ann
    Van Eygen, Koen
    Lejeune, Marie
    Deeren, Dries
    Nifosi, Gianfilippo
    Triffet, Agnes
    Vrelust, Inge
    Bekaert, Julie
    Beck, Michael
    Selleslag, Dominik
    BLOOD, 2019, 134
12345